Preoperative cardiac management of the patient for non-cardiac surgery: An individualized and evidence-based approach

British Journal of Anaesthesia

Volumn 107, Issue 1, 2011, Pages 83-96

  Priebe, H J ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

cardiac management, preoperative; surgery, non cardiac; surgery, preoperative period

Indexed keywords

ACETYLSALICYLIC ACID; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRASUGREL; TICAGRELOR;

ALGORITHM; ANGIOCARDIOGRAPHY; ANTICOAGULANT THERAPY; CARDIOPULMONARY EXERCISE TEST; CARDIOVASCULAR RISK; CARDIOVASCULAR SYSTEM; CORONARY ARTERY DISEASE; DUKE ACTIVITY STATUS INDEX; EVIDENCE BASED MEDICINE; EXERCISE ELECTROCARDIOGRAPHY; FUNCTIONAL STATUS; HEART FAILURE; HEART MUSCLE REVASCULARIZATION; HEART SURGERY; HUMAN; HYPERTENSION; INCREMENTAL SHUTTLE WALK TEST; MYOCARDIAL PERFUSION IMAGING; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NON HEART SURGERY; PERSONALIZED MEDICINE; PREOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; STRESS ECHOCARDIOGRAPHY; SURGICAL PATIENT; SURGICAL RISK; TREATMENT INDICATION; VALVULAR HEART DISEASE;

EID: 79959386484     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aer121     Document Type: Review

References (106)

1. Poldermans D, Bax J, Boersma E, et al. Guidelines for pre-operat-ive cardiac risk assessment and peri-operative cardiac management in non-cardiac surgery: the Task Force for Pre-operative Cardiac Risk Assessment and Peri-operative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA). Eur Heart J 2009; 30: 2769-812
2. Hammill BG, Curtis LH, Bennett-Guerrero E, et al. Impact of heart failure on patients undergoing major noncardiac surgery. Anesthesiology 2008; 108: 559-67 (Pubitemid 351440575)
3. Kheterpal S, O'Reilly M, Englesbe M, et al. Pre-operative and intra-operative predictors of cardiac adverse events after general, vascular, and urological surgery. Anesthesiology 2009; 110: 58-66
4. Monin J-L, Lancellotti P, Monchi M, et al. Risk score for predicting outcome in patients with asymptomatic aortic stenosis. Circulation 2009; 120: 69-75
5. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363: 1597-607
6. Tamburino C, Capodanno D, Ramando A, et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 2011; 123: 299-308
7. Buellesfeld L, Windecker S. Transcatheter aortic valve implantation: the evidence is catching up with reality. Eur Heart J 2011; 32: 133-7
8. Eltchaninoff H, Prat A, Gilard M, et al. Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry. Eur Heart J 2011; 32: 191-7
9. Zahn R, Gerckens U, Grube E, et al. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur Heart J 2011; 32: 198-204
10. Older P, Smith R, Courtney P, Hone R. Pre-operative evaluation of cardiac failure and ischemia in elderly patients by cardiopul-monary exercise testing. Chest 1993; 104: 701-4 (Pubitemid 23268935)
11. Older P, Hall A, Hader R. Cardiopulmonary exercise testing as a screening test for peri-operative management of major surgery in the elderly. Chest 1999; 116: 355-62 (Pubitemid 29382118)
12. Win T, Jackson A, Sharples L, et al. Cardiopulmonary exercise tests and lung cancer surgical outcome. Chest 2005; 127: 1159-65 (Pubitemid 46224276)
13. Murray P, Whiting P, Hutchinson SP, Ackroyd R, Stoddard CJ, Billings C. Pre-operative shuttle walking testing and outcome after oesophagogastrectomy. Br J Anaesth 2007; 99: 809-11 (Pubitemid 351773382)
14. Carlisle J, Swart M. Mid-term survival after abdominal aortic aneurysm surgery predicted by cardiopulmonary exercise testing. Br J Surg 2007; 94: 966-9 (Pubitemid 47236540)
15. Crawford RS, Cambria RP, Abularrage CJ, et al. Pre-operative functional status predicts peri-operative outcomes after infrain-guinal bypass surgery. J Vasc Surg 2010; 51: 351-9
16. Hlatky MA, Boineau RE, Higginbotham MB, et al. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol 1989; 64: 651-4 (Pubitemid 19230238)
17. Struthers R, Erasmus P, Holmes K, Warman P, Collingwood A, Sneyd JR. Assessing fitness for surgery: a comparison of questionnaire, incremental shuttle walk, and cardiopulmonary exercise testing in general surgical patients. Br J Anaesth 2008; 101: 774-80
18. Fleisher LA, Beckman JA, Brown KA, et al. 2009 ACCF/AHA focused update on peri-operative beta blockade incorporated into the ACC/AHA 2007 guidelines on peri-operative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines. Circulation 2009; 120: e169-276; J Am Coll Cardiol 2009; 54: 13-118
19. Byrne NM, Hills AP, Hunter GR, Weinsier RL, Schutz Y. Metabolic equivalent: one size does not fit all. J Appl Physiol 2005; 99: 1112-9 (Pubitemid 41214530)
20. Singh SJ, Morgan MD, Hardman AE, Rowe C, Bardsley PA. Comparison of oxygen uptake during a conventional treadmill test and the shuttle walking test in chronic airflow limitation. Eur Respir J 1994; 7: 2016-20 (Pubitemid 24366294)
21. Onorati P, Antonucci R, Valli G, et al. Non-invasive evaluation of gas exchange during a shuttle walking test vs. a 6-min walking test to assess exercise tolerance in COPD patients. Eur J Appl Physiol 2003; 89: 331-6 (Pubitemid 36748692)
22. Win T, Jackson A, Groves AM, Sharples LD, Charman SC, Laroche CM. A comparison of shuttle walk with measured peak oxygen consumption in patients with operable lung cancer. Thorax 2006; 61: 57-60 (Pubitemid 43106979)
23. Older P, Smith R. Experience with the pre-operative invasive measurement of haemodynamic, respiratory and renal function in 100 elderly patients scheduled for major abdominal surgery. Anaesth Intensive Care 1988; 16: 395-8
24. Balady GJ, Arena R, Sietsema K, et al. Clinician's guide to cardi-opulmonary exercise testing in adults. A scientific statement from the American Heart Association. Circulation 2010; 122: 191-225
25. Arena R, Sietsema KE. Cardiopulmonary exercise testing in the clinical evaluation of patients with heart and lung disease. Circulation 2011; 123: 668-80
26. Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999; 100: 1043-9 (Pubitemid 29416229)
27. Ridley S. Cardiac scoring systems\-what is there value? Anaesthesia 2003; 58: 985-91 (Pubitemid 37254178)
28. Priebe HJ. Peri-operative myocardial infarction\-aetiology and prevention. Br J Anaesth 2005; 95: 3-19
29. Landesberg G, Beattie WS, Mosseri M, Jaffe AS, Alpert JS. Peri-operative myocardial infarction. Circulation 2009; 119: 2936-44
30. Braunwald E. Biomarkers in heart failure. N Engl J Med 2008; 358: 2148-59
31. Karthikeyan G, Moncur RA, Levine O, et al. Is a pre-operative brain natriuretic peptide or N-terminal pro-B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and meta-analysis of observational studies. J Am Coll Cardiol 2009; 54: 1599-606
32. Ryding A, Kumar S, Worthington AM, Burgess D. Prognostic value of brain natriuretic peptide in noncardiac surgery: a meta-analysis. Anesthesiology 2009; 111: 311-9
33. Feringa HHH, Schouten O, Dunkelgrun M, et al. Plasma N-terminal pro-B-type natriuretic peptide as long-term prognostic marker after major vascular surgery. Heart 2007; 93: 226-31 (Pubitemid 46180301)
34. Owens CD, Ridker PM, Belkin M, et al. Elevated C-reactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgery. J Vasc Surg 2007; 45: 2-9 (Pubitemid 46038651)
35. Bolliger D, Seeberger M, Lurati Buse GAL, et al. A preliminary report on the prognostic significance of pre-operative brain natriuretic peptide and postoperative cardiac troponin in patients undergoing major vascular surgery. Anesth Analg 2009; 108: 1069-75
36. Goei D, Hoeks SE, Boersma E, et al. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients. Coron Art Dis 2009; 20: 219-24
37. Choi J-H, Cho DK, Song Y-B, et al. Pre-operative NT-proBNP and CRP predict peri-operative major cardiovascular events in non-cardiac surgery. Heart 2010; 96: 56-62
38. Bolliger D, Seeberger MD, Filipovic M. Pre-operative cardiac risk assessment in noncardiac surgery: are natriuretic peptides the magic bullet? J Am Coll Cardiol 2009; 54: 1607-8
39. McFalls EO, Ward HB, Moritz TE, et al. Coronary-artery revascular-ization before elective major vascular surgery. N Engl J Med 2004; 351: 2795-804 (Pubitemid 40051903)
40. Poldermans D, Schouten O, Vidakovic R, et al. A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery: the DECREASE-V Pilot Study. J Am Coll Cardiol 2007; 49: 1763-9 (Pubitemid 46617863)
41. Schouten O, van Kuijk J-P, Flu W-J, et al. Long-term outcome of prophylactic coronary revascularization in cardiac high-risk patients undergoing major vascular surgery (from the randomized DECREASE-V pilot study). Am J Cardiol 2009; 103: 897-901
42. Monaco M, Stassano P, Di Tommaso L, et al. Systematic strategy of prophylactic coronary angiography improves long-term outcome after major vascular surgery in medium-to high-risk patients: a prospective, randomized study. J Am Coll Cardiol 2009; 54: 989-96
43. Landesberg G, Mosseri M. Prophylactic pre-operative coronary revascularization: is the phoenix awakening? J Am Coll Cardiol 2009; 54: 997-8
44. Illuminati G, Ricco J-B, Greco C, et al. Systematic pre-operative coronary angiography and stenting improves postoperative results of carotid endarterectomy in patients with asymptomatic coronary artery disease: a randomised controlled trial. Eur J Vasc Endovasc Surg 2010; 39: 139-45
45. Prasad A, Herrmann J. Myocardial infarction due to percutaneous coronary intervention. N Engl J Med 2011; 364: 453-64
46. Garcia S, Moritz TE, Ward HB, et al. Usefulness of revasculariza-tion of patients with multivessel coronary artery disease before elective vascular surgery for abdominal aortic and peripheral occlusive disease. Am J Cardiol 2008; 102: 809-13
47. Schouten O, Dunkelgrun M, Feringa HHH, et al. Myocardial damage in high-risk patients undergoing elective endovascular or open infrarenal abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg 2007; 33: 544-9 (Pubitemid 46547472)
48. Wijns W, Kolh P, Danchin N, et al. Guidelines on myocardial revascularization. The Task Force on Myocardial Revasculariza-tion of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2010; 31: 2501-55
49. Ward HB, Kelly RF, Thottapurathu L, et al. Coronary artery bypass grafting is superior to percutaneous coronary intervention in prevention of peri-operative myocardial infarctions during subsequent vascular surgery. Ann Thorac Surg 2006; 82: 795-801
50. Biccard BM, Rodseth RN. A meta-analysis of the prospective randomised trials of coronary revascularisation before noncardiac vascular surgery with attention to the type of coronary revascularisation performed. Anaesthesia 2009; 64: 1105-13
51. Boden WE, O'Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007; 356: 1503-16 (Pubitemid 46588415)
52. Mythen M. Pre-operative coronary revascularisation before non-cardiac surgery: think long and hard before making a pre-operative referral. Anaesthesia 2009; 64: 1048-50
53. Howard-Alpe GM, de Bono J, Hudsmith L, Orr WP, Foex P, Sear JW. Coronary artery stents and non-cardiac surgery. Br J Anaesth 2007; 98: 560-74 (Pubitemid 47078669)
54. Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation 2005; 111: 3481-8 (Pubitemid 40923403)
55. Levin R. Plaque vulnerability: pathologic form and patient fate. J Am Coll Cardiol 2010; 55: 133-4
56. Diamond GA, Kaul S. COURAGE under fire: on the management of stable coronary disease. J Am Coll Cardiol 2007; 50: 1604-9 (Pubitemid 47532335)
57. Hochman JS, Steg PG. Does preventive PCI work? N Engl J Med 2007; 356: 1572-4 (Pubitemid 46588423)
58. O'Rourke RA. Optimal medical therapy is a proven option for chronic stable angina. J Am Coll Cardiol 2008; 52: 905-7
59. Peterson ED, Rumsfeld JS. Finding the courage to reconsider medical therapy for stable angina. N Engl J Med 2008; 359: 751-3
60. Spahn DR, Howell SJ, Delabays A, Chassot P-G. Coronary stents and peri-operative anti-platelet regimen: dilemma of bleeding and stent thrombosis. Br J Anaesth 2006; 96: 675-7 (Pubitemid 43786680)
61. Flu WJ, Hoeks SE, van Kuijk JP, Bax JJ, Poldermans D. Treatment recommendations to prevent myocardial ischemia and infarction in patients undergoing vascular surgery. Curr Treat Options Cardiovasc Med 2009; 11: 33-44
62. Voûte MT, Winkel TA, Poldermans D. Optimal medical management around the time of surgery. Heart 2010; 96: 1842-8
63. POISE Study Group. Effects of extended-release metoprolol suc-cinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 2008; 371: 1839-47
64. Fleischmann KE, Beckman JA, Buller CE, et al. ACCF/AHA focused update on peri-operative beta blockade. Circulation 2009; 120: 2123-51
65. Ragoonanan TE, Beattie WS, Mazer CD, et al. Metoprolol reduces cerebral tissue oxygen tension after acute hemodilution in rats. Anesthesiology 2009; 111: 988-1000
66. Weiskopf RB. Peri-operative use of b-adrenergic antagonists and anemia: known knowns, known unknowns, unknown unknowns; and unknown knowns. Anesthesiology 2010; 112: 12-5
67. Beattie WS, Wijeysundera DN, Karkouti K, et al. Acute surgical anemia influences the cardioprotective effects of b-blockade: a single-center, propensity-matched cohort study. Anesthesiology 2010; 112: 25-33
68. Libby P, Aikawa M. Mechanisms of plaque stabilization with statins. Am J Cardiol 2003; 91: 4B-8B
69. Ito MK, Talbert RL, Tsimikas S. Statin-associated pleiotropy: possible beneficial effects beyond cholesterol reduction. Pharma-cotherapy 2006; 26: 85S-97S (Pubitemid 43993553)
70. Ray KK, Cannon CP. The potential relevance of the multiple lipid-independent (pleiotropic) effects of statins in the management of acute coronary syndromes. J Am Coll Cardiol 2005; 46: 1425-33 (Pubitemid 41446176)
71. Klingenberg R, Hansson GK. Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies. Eur Heart J 2009; 30: 2838-44
72. Hindler K, Shaw A, Samuels J, Fulton S, Collard C, Riedel B. Improved postoperative outcomes associated with pre-operative statin therapy. Anesthesiology 2006; 105: 1260-72 (Pubitemid 44808591)
73. Feringa HHH, Schouten O, Karagiannis SE, et al. Intensity of statin therapy in relation to myocardial ischemia, troponin T release, and clinical cardiac outcome in patients undergoing major vascular surgery. J Am Coll Cardiol 2007; 50: 1649-56 (Pubitemid 47562667)
74. Boushra NN, Muntazar M. Review article: the role of statins in reducing peri-operative cardiac risk: physiologic and clinical perspectives. Can J Anaesth 2006; 53: 1126-47 (Pubitemid 44767074)
75. Kapoor AS, Kanji H, Buckingham J, Devereaux PJ, McAlister FA. Strength of evidence for peri-operative use of statins to reduce cardiovascular risk: systematic review of controlled studies. Br Med J 2006; 333: 1149-56
76. Biccard BM. A peri-operative statin update for non-cardiac surgery. Part II: Statin therapy for vascular surgery and peri-operative statin trial design. Anaesthesia 2008; 63: 162-71
77. Schouten O, Boersma E, Hoeks SE, et al. Fluvastatin and peri-operative events in patients undergoing vascular surgery. N Engl J Med 2009; 361: 980-9
78. Le Manach Y, Godet G, Coriat P, et al. The impact of postoperative discontinuation or continuation of chronic statin therapy on cardiac outcome after major vascular surgery. Anesth Analg 2007; 104: 1326-33 (Pubitemid 46795280)
79. Schouten O, Hoeks SE, Welten GMJM, et al. Effect of statin withdrawal on frequency of cardiac events after vascular surgery. Am J Cardiol 2007; 100: 316-20 (Pubitemid 47041993)
80. Kersten JR, Fleisher LA. Statins. The next advance in cardiopro-tection? Anesthesiology 2006; 105: 1079-80
81. Feldman LS, Broman DJ. Peri-operative statins: more than lipid-lowering? Cleveland Clin J Med 2008; 75: 654-62
82. Poldermans D. Statins and noncardiac surgery: current evidence and practical considerations. Cleveland Clin J Med 2009; 76 (Suppl 4): S79-83
83. Briguori C, Visconti G, Focaccio A, et al. Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction. J Am Coll Cardiol 2009; 54: 2157-63
84. Cay S, Cagirci G, Sen N, Balbay Y, Durmaz T, Aydogdu S. Prevention of peri-procedural myocardial injury using a single high loading dose of rosuvastatin. Cardiovasc Drug Ther 2010; 24: 41-7
85. Sun Y-P, Zhu B-Q, Browne AEM, et al. Comparative effects of ACE inhibitors and an angiotensin receptor blocker on atherosclerosis and vascular function. J Cardiovasc Pharmacol Ther 2001; 6: 175-81 (Pubitemid 32977713)
86. Ferrari E, Benhamou M, Cerboni P, Baudouy M. Coronary syndromes following aspirin withdrawal: a special risk for late stent thrombosis. J Am Coll Cardiol 2005; 45: 456-9 (Pubitemid 40186800)
87. Biondi-Zoccai GGL, Lotrionte M, Agostoni P, et al. A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50 279 patients at risk for coronary artery disease. Eur Heart J 2006; 27: 2667-74 (Pubitemid 44729867)
88. Smith SC Jr, Allen J, Blair SN, et al. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006; 113: 2363-72 (Correction: Circulation 2006; 113: e847) (Pubitemid 43947981)
89. Burger W, Chemnitius J-M, Kneissl GD, Rücker G. Low-dose aspirin for secondary cardiovascular prevention\-cardiovascular risks after its peri-operative withdrawal versus bleeding risks with its continuation\-review and meta-analysis. J Intern Med 2005; 257: 399-414 (Pubitemid 40604544)
90. Chassot P-G, Delabays A, Spahn DR. Peri-operative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction. Br J Anaesth 2007; 99: 316-28 (Pubitemid 47321534)
91. Collet JP, Montalescot G, Blanchet B, et al. Impact of prior use or recent withdrawal of oral antiplatelet agents on acute coronary syndromes. Circulation 2004; 110: 2361-7 (Pubitemid 39407340)
92. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. J Am Med Assoc 2005; 293: 2126-30 (Pubitemid 40617065)
93. Eisenstein EL, Anstrom KJ, Kong DF, et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. J Am Med Assoc 2007; 297: 159-68 (Pubitemid 46089732)
94. Ho PM, Peterson ED, Wang L, et al. Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome. J Am Med Assoc 2008; 299: 532-9 (Pubitemid 351222546)
95. Silber S, Albertsson P, Avilès FF, et al. Guidelines for percutaneous coronary interventions: the Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 2005; 26: 804-47
96. Bassand JP, Hamm CW, Ardissino D, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 2007; 28: 1598-660
97. Van de Werf F, Bax J, Betriu A, et al. Management of acute myo-cardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology. Eur Heart J 2008; 29: 2909-45
98. Grines CL, Bonow RO, Casey DE, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents. A science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of Physicians. Circulation 2007; 115: 813-8 (Pubitemid 46294748)
99. Casterella PJ, Tcheng JE. Review of the 2005 American College of Cardiology, American Heart Association, and Society for Cardiovascular Interventions guidelines for adjunctive pharmacologic therapy during percutaneous coronary interventions: practical implications, new clinical data, and recommended guideline revisions. Am Heart J 2008; 155: 781-90
100. Riddell JW, Chiche L, Plaud B, Hamon M. Coronary stents and noncardiac surgery. Circulation 2007; 116: e378-82 (Pubitemid 350287111)
101. Practice alert for the peri-operative management of patients with coronary artery stents: a report by the American Society of Anesthesiologists Committee on Standards and Practice Parameters. Anesthesiology 2009; 110: 22-3
102. Schouten O, van Domburg RT, Bax JJ, et al. Noncardiac surgery after coronary stenting: early surgery and interruption of anti-platelet therapy are associated with an increase in major adverse cardiac events. J Am Coll Cardiol 2007; 49: 122-4 (Pubitemid 46026891)
103. Rabbitts JA, Nuttall GA, Brown MJ, et al. Cardiac risk of noncar-diac surgery after percutaneous coronary intervention with drug-eluting stents. Anesthesiology 2008; 109: 596-604
104. Reilly CS. Can we accurately assess an individual's peri-operative risk? Br J Anaesth 2008; 101: 747-9
105. Kehlet H, Mythen M. Why is the surgical high-risk patient still at risk? Br J Anaesth 2011; 106: 289-91
106. Grocott MPW, Pearse RM. Prognostic studies of peri-operative risk: robust methodology is needed. Br J Anaesth 2010; 105: 243-5